ライフサイエンスコーパス: sexually transmitted disease

1 d 93% (14/15) having a documented history of sexually transmitted disease.

2 s trichomonosis, the most prevalent nonviral sexually transmitted disease.

3 ogenital tract infection by Chlamydia causes sexually transmitted disease.

4 trachomatis, the leading cause of bacterial sexually transmitted disease.

5 n of increased risk was found for history of sexually transmitted disease.

6 d 93% (14/15) having a documented history of sexually transmitted disease.

7 nts attending United States clinics treating sexually transmitted disease.

8 medical service utilization, disability, and sexually transmitted disease.

9 -negative bacterium that causes chancroid, a sexually transmitted disease.

10 obligate intracellular pathogen that causes sexually transmitted disease.

11 s, and it can have social ramifications as a sexually transmitted disease.

12 e etiological agent of blinding trachoma and sexually transmitted disease.

13 is is a pathogen responsible for a prevalent sexually transmitted disease.

14 n-] strains, probably reflecting its being a sexually transmitted disease.

15 uals globally, causing blinding trachoma and sexually transmitted disease.

16 in clinics for the treatment of persons with sexually transmitted diseases.

17 rial pathogen linked to urethritis and other sexually transmitted diseases.

18 th problems, including blinding trachoma and sexually transmitted diseases.

19 typing of C. trachomatis strains that cause sexually transmitted diseases.

20 have an effect in the patterns of spread of sexually transmitted diseases.

21 ndidiasis has a much weaker association with sexually transmitted diseases.

22 ould play an important role in the spread of sexually transmitted diseases.

23 gynecologic complications and acquisition of sexually transmitted diseases.

24 s deficiency could predispose individuals to sexually transmitted diseases.

25 y and physiology, and a higher prevalence of sexually transmitted diseases.

26 ium responsible for ocular, respiratory, and sexually transmitted diseases.

27 ection is the most common cause of bacterial sexually transmitted diseases.

28 uggest their importance in immunity to other sexually transmitted diseases.

29 way a core population does in the setting of sexually transmitted diseases.

30 nts are needed to protect men and women from sexually transmitted diseases.

31 analysis was controlled for the presence of sexually transmitted diseases.

32 f the genital mucosae are a leading cause of sexually transmitted diseases.

33 ause of preventable blindness worldwide, and sexually transmitted diseases.

34 but no effect was seen among men with other sexually transmitted diseases.

35 scuss global initiatives for surveillance of sexually transmitted diseases.

36 ne effectors is the goal of vaccines against sexually transmitted diseases.

37 s, including a prominent role for coincident sexually transmitted diseases.

38 event human immunodeficiency virus and other sexually transmitted diseases.

39 oxic agents are needed to protect women from sexually transmitted diseases.

40 rol group received standard counseling about sexually transmitted diseases.

41 ss could be made towards improved control of sexually transmitted diseases.

42 y to address the current epidemic problem of sexually transmitted diseases.

43 ymptomatic BV who were also at high risk for sexually transmitted diseases.

44 bacterial vaginosis (BV) and acquisition of sexually transmitted diseases.

45 herpes simplex is one of the most prevalent sexually transmitted diseases.

46 d difficulties which increases the risks for sexually transmitted diseases.

47 trol and Prevention treatment guidelines for sexually transmitted diseases.

48 esting for other causes of liver disease and sexually transmitted diseases.

49 c plague, secondary hospital infections, and sexually transmitted diseases.

50 ally transmitted pathogens, particularly for sexually transmitted diseases.

51 vulnerability to predation, and exposure to sexually transmitted diseases.

52 une surveillance and in host defense against sexually transmitted diseases.

53 the exact role local IgG plays in preventing sexually transmitted diseases.

54 with multiple partners or those at risk for sexually transmitted diseases (0.4% to 1.8% per year).

55 prevention (2.4%), mental health (4.1%), or sexually transmitted diseases (2.7%).

56 mmunodeficiency virus (HIV) type 1 and other sexually transmitted diseases, a prospective cohort stud

57 nse to treatment, relapse rate, and risk for sexually-transmitted-disease acquisition among women wit

58 ociated with reported lifetime experience of sexually transmitted diseases (adjusted OR 3.69 [95% CI

59 the bacterium that causes gonorrhea, a major sexually transmitted disease and a significant cofactor

60 bal health burden due to its prevalence as a sexually transmitted disease and as the causative agent

61 chomatis reference serotypes responsible for sexually transmitted disease and blinding trachoma synth

62 acterial pathogen that is a leading cause of sexually transmitted disease and blinding trachoma.

63 in individuals with multiple sex partners or sexually transmitted disease and in pregnant women.

64 ovariants are the leading cause of bacterial sexually transmitted disease and infectious preventable

65 amydia trachomatis (Ctr) is a major cause of sexually transmitted disease and infertility worldwide.

66 Herpes infections are among the most common sexually transmitted diseases and are the most common ca

67 eographic areas with high prevalence of HIV, sexually transmitted diseases and genital cancers.

68 reased risk for bloodborne viral infections, sexually transmitted diseases, and mental health symptom

69 ness for acquired immunodeficiency syndrome, sexually transmitted diseases, and tuberculosis as a gro

70 Sexually transmitted diseases are increasing rapidly in

71 porting a history of influenza/pneumonia and sexually transmitted disease around the time of pregnanc

72 rial pathogen linked to urethritis and other sexually transmitted diseases as well as respiratory and

73 Trichomoniasis is a common sexually transmitted disease associated with preterm bir

74 obiotypes associated with either trachoma or sexually transmitted diseases, but differences within th

75 cal microbicides are being sought to prevent sexually transmitted diseases by inactivating pathogens

76 elopment of a protective vaccine against the sexually transmitted disease caused by Chlamydia trachom

77 Gonorrhea, a sexually transmitted disease caused by Neisseria gonorrh

78 Syphilis is a complex sexually transmitted disease caused by the spirochetal b

79 Haemophilus ducreyi causes the sexually transmitted disease chancroid and a chronic lim

80 Haemophilus ducreyi causes the sexually transmitted disease chancroid in adults and cut

81 mophilus ducreyi, the etiologic agent of the sexually transmitted disease chancroid, has been shown t

82 Haemophilus ducreyi causes the sexually transmitted disease chancroid, which facilitate

83 uman pathogen and the causative agent of the sexually transmitted disease chancroid.

84 llidum is the causative agent of syphilis, a sexually transmitted disease characterized by widespread

85 were collected from individuals attending a sexually transmitted disease clinic and three HIV clinic

86 n to occur in immunocompromised individuals, sexually transmitted disease clinic attendees, and child

87 ded the San Francisco, California, municipal sexually transmitted disease clinic between 1989 and 199

88 m 3 consecutive groups of 10 men attending a sexually transmitted disease clinic by use of (1) a sali

89 rleans, Louisiana, public family planning or sexually transmitted disease clinic from July 1995 to Ju

90 fied among men presenting for screening at a sexually transmitted disease clinic in Columbus, Ohio, w

91 f genital ulcers in patients presenting to a sexually transmitted disease clinic in Dakar, Senegal, a

92 tion, using patient data from a metropolitan sexually transmitted disease clinic in Denver, Colorado

93 atients repeatedly tested for the virus at a sexually transmitted disease clinic in New Orleans, Loui

94 genitalium infection in patients attending a sexually transmitted disease clinic in San Antonio, TX,

95 ecton Dickinson Co.) in MSM seen at the city sexually transmitted disease clinic in San Francisco, CA

96 imens from women recruited in the Harborview Sexually Transmitted Disease Clinic in Seattle from 1984

97 At the municipal sexually transmitted disease clinic in Seattle, Washingt

98 At a sexually transmitted disease clinic in Seattle, Washingt

99 pharyngeal gonorrhea during 1993-2011, at a sexually transmitted disease clinic in Seattle, Washingt

100 surveillance was conducted in a Minneapolis sexually transmitted disease clinic on 28 newly diagnose

101 m a prospective cohort study of 1,122 female sexually transmitted disease clinic patients in Alabama

102 STARHS was offered to sexually transmitted disease clinic patients to estimate

103 o have sex with men (MSM) who were seen in a sexually transmitted disease clinic provided 506 pharyng

104 -label, noncomparative trial in 5 outpatient sexually transmitted disease clinic sites in Alabama, Ca

105 atic, uninfected control women from an urban sexually transmitted disease clinic to determine if ther

106 the ages of 16 and 50 years presenting to a sexually transmitted disease clinic with urogenital gono

107 mptomatic males at San Francisco's municipal sexually transmitted disease clinic, a participant in th

108 on of infection in women and men attending a sexually transmitted disease clinic.

109 ipants were men aged 18-70 years attending a sexually transmitted disease clinic.

110 a vaginitis workup, whereas those seen at a sexually transmitted diseases clinic could be more likel

111 Data were collected in an urban sexually transmitted diseases clinic from patients who h

112 lish-speaking males >/=16 years, attending a sexually transmitted diseases clinic in Seattle, Washing

113 A cross-sectional study was conducted in a sexually transmitted diseases clinic to determine the pr

114 Consecutive men attending a sexually transmitted diseases clinic were enrolled in a

115 Men attending a sexually transmitted diseases clinic were tested for tri

116 human immunodeficiency virus clinics and one sexually transmitted diseases clinic) located in Birming

117 men with and without NGU attending an urban sexually transmitted diseases clinic.

118 se was assessed in 1179 patients attending a sexually transmitted diseases clinic.

119 ) in heterosexual men presenting to an urban sexually transmitted diseases clinic.

120 n C. trachomatis-infected subjects seen at a sexually transmitted diseases clinic.

121 highest rate was found in patients tested at sexually transmitted disease clinics (43%).

122 entions conducted at five publicly funded US sexually transmitted disease clinics between 1993 and 19

123 inal swab specimens from 936 women attending sexually transmitted disease clinics in Seattle, Wash. (

124 eillance Project (GISP) from sentinel public sexually transmitted disease clinics in the USA, includi

125 Samples from patients attending sexually transmitted disease clinics were collected in d

126 More than 3,000 women attending two sexually transmitted disease clinics were enrolled in th

127 23 acute HIV infections, 16 were detected at sexually transmitted disease clinics.

128 d 18 to 40 attending primary health care and sexually transmitted disease clinics.

129 m high-risk female populations attending two sexually transmitted disease clinics.

130 orrhoeae are common among patients attending sexually transmitted disease clinics.

131 cantly higher prevalence of substance abuse, sexually transmitted diseases, decompensated cirrhosis,

132 testinal, and gynaecological signs including sexually-transmitted diseases, depression, and post-trau

133 Health consequences of sexually transmitted diseases disproportionately affect

134 d women, with or without symptoms, attending sexually transmitted disease, family planning, and obste

135 ing the female reproductive tract, including sexually transmitted diseases, fungal and bacterial infe

136 The global incidence of the sexually transmitted disease gonorrhea is expected to ri

137 eria gonorrhoeae, the causative agent of the sexually transmitted disease gonorrhea, can be studied u

138 bacterial meningitis and septicemia, and the sexually transmitted disease gonorrhea, respectively.

139 N. gonorrhoeae, the etiological agent of the sexually transmitted disease gonorrhea.

140 N. gonorrhoeae causes the sexually transmitted disease gonorrhoea, but also causes

141 he gonococcus) is the causative agent of the sexually transmitted disease gonorrhoea.

142 smitted diseases, but differences within the sexually transmitted disease group have not yielded reli

143 Classic modeling of sexually transmitted diseases has focused on modeling be

144 Examples include limited sexually transmitted disease, HIV and pregnancy testing;

145 dividuals exposed to a mild and long-lasting sexually transmitted disease, i.e. without disease-induc

146 cause genital warts, and are the most common sexually transmitted disease in many countries.

147 dia trachomatis is the most common bacterial sexually transmitted disease in the United States and a

148 omatis is the most common cause of bacterial sexually transmitted disease in the United States and th

149 omatis is the most common cause of bacterial sexually transmitted disease in the United States, as we

150 onorrhoeae are the two most common causes of sexually transmitted disease in the United States.

151 The infection is also a leading cause of sexually transmitted disease in the United States.

152 hlamydia trachomatis is the leading cause of sexually transmitted disease in the United States.

153 tis infections are the most common bacterial sexually transmitted disease in the United States.

154 matis infection is the most common bacterial sexually transmitted disease in the United States.

155 ntly no other animal model available for any sexually transmitted disease in which the disease or the

156 an immunodeficiency virus type 1 (HIV-1) and sexually transmitted diseases in a population of sex wor

157 n appears to reduce the infection of several sexually transmitted diseases in randomized control tria

158 IUDs affect long-term fertility or increase sexually transmitted diseases in teens.

159 on in Trinidad, 83 samples from a clinic for sexually transmitted diseases in the Bahamas, 10 confirm

160 tion in women with anogenital warts or other sexually transmitted diseases, in their sex partners, an

161 ays have been performed for the detection of sexually transmitted diseases, including Chlamydia trach

162 mcision provides substantial protection from sexually transmitted diseases, including HIV-1, and the

163 ucts topically applied for the prevention of sexually transmitted diseases, including HIV-1.

164 condition associated with increased risk of sexually transmitted diseases, including human immunodef

165 provides protection from the acquisition of sexually transmitted diseases, including human immunodef

166 ute of transmission for most respiratory and sexually transmitted diseases, including human immunodef

167 nic women are disproportionately affected by sexually transmitted diseases, including the acquired im

168 esting; given the high rates of asymptomatic sexually transmitted disease infection, universal screen

169 cal agent of blinding trachoma and bacterial sexually transmitted diseases, infections that afflict h

170 Sexually transmitted disease intervention programs based

171 mating partners, indicating that the risk of sexually transmitted disease is likely to be a major fac

172 genitalium, a human pathogen associated with sexually transmitted diseases, is capable of causing chr

173 the leading bacterial agent responsible for sexually transmitted diseases, is required to invade gen

174 genitalium, a human pathogen associated with sexually transmitted diseases, is unique in that it has

175 al gene transfer (LGT) have been detected in sexually transmitted disease isolates of Chlamydia trach

176 gen systems, particularly macroparasites and sexually transmitted diseases, it has been found that ap

177 Because dogs are particularly resilient to sexually transmitted diseases, it has been proposed that

178 y pathogen, causing bovine trichomoniasis, a sexually transmitted disease leading to infertility and

179 omatis infection is the most common cause of sexually transmitted disease, leading to female pelvic i

180 is, the causative agent of trachoma and many sexually transmitted diseases , leads to the accumulatio

181 atitis include benign prostatic hyperplasia, sexually transmitted disease, lower urinary tract sympto

182 t for human trichomoniasis, is a problematic sexually transmitted disease mainly in women, where it m

183 produced during opportunistic infections or sexually transmitted diseases, may predispose macrophage

184 homatis, the causative agent of trachoma and sexually transmitted diseases, multiply in a vacuolar co

185 Women at low risk of sexually transmitted diseases (n = 210) were recruited i

186 1986 and 1998-2000 were having a history of sexually transmitted disease, number of sex partners, an

187 intracellular bacterial pathogens that cause sexually transmitted diseases, ocular infections and aty

188 n the clinical manifestations of syphilis, a sexually transmitted disease of humans caused by spiroch

189 oncepts borrowed from the study of venereal (sexually transmitted) diseases of animals do not adequat

190 nal swabs were obtained from women attending sexually transmitted disease or family planning clinics

191 The most common features were a history of sexually transmitted disease or pelvic inflammatory dise

192 Inflammation did not correlate with sexually transmitted diseases or HIV disease stage.

193 = 3.3; 95% CI: 1.7, 6.2), and history of any sexually transmitted disease (OR = 2.0; 95% CI: 1.1, 3.5

194 ose unflattering (drug use, poor grades, and sexually transmitted diseases) or flattering (blood dona

195 tudies have reported that infection with the sexually transmitted disease pathogen Neisseria gonorrho

196 ated activation of gene transcription in the sexually transmitted disease pathogen Neisseria gonorrho

197 n promise in development of immunity against sexually transmitted disease pathogens, in part due to t

198 Frequently seen medical conditions including sexually transmitted diseases, pregnancy, and psychiatri

199 STC-1 included exposure to sexually transmitted diseases, presumptive CT treatment

200 School-based sexually transmitted disease programs can reach the majo

201 M. genitalium infection in women attending a sexually transmitted disease-related health clinic in Sa

202 he genitourinary tracts of women attending a sexually transmitted disease-related health clinic, plus

203 the provision of contraceptive services and sexually transmitted disease screening from requirements

204 so than interventions such as improvement of sexually transmitted disease services and universal prov

205 of the following infection risks: history of sexually transmitted disease, sex with men (for men), in

206 Interviews focused on history of sexually transmitted diseases, sexual behavior, and ciga

207 ing trachoma, the leading cause of bacterial sexually transmitted diseases, significant respiratory p

208 Biomedical innovations for sexually transmitted disease (STD) and HIV prevention ha

209 Men attending a sexually transmitted disease (STD) clinic for a new comp

210 cohorts of subjects who had visited either a sexually transmitted disease (STD) clinic for genital tr

211 and clinical factors among women attending a sexually transmitted disease (STD) clinic in New Orleans

212 Case patients were men who attended a sexually transmitted disease (STD) clinic in Seattle, Wa

213 high prevalences have been identified among sexually transmitted disease (STD) clinic patients and i

214 was determined among 1766 patients attending sexually transmitted disease (STD) clinics and enrolled

215 We examined attendance at sexually transmitted disease (STD) clinics and the preva

216 presenting with urethritis symptoms to 6 US sexually transmitted disease (STD) clinics during June 2

217 en who underwent HIV testing while attending sexually transmitted disease (STD) clinics in Baltimore,

218 roject AWARE randomized 5012 patients from 9 sexually transmitted disease (STD) clinics in the United

219 planning, obstetrics/gynecology (OB/GYN), or sexually transmitted disease (STD) clinics in the United

220 ed with rectal CT and/or GC in New York City sexually transmitted disease (STD) clinics was compared

221 fection was studied among 4128 patients from sexually transmitted disease (STD) clinics who were enro

222 T testing and infections among MSM attending sexually transmitted disease (STD) clinics.

223 between depression and HIV risk behaviors or sexually transmitted disease (STD) diagnosis at an urban

224 Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) for which a vaccine i

225 important cause of preventable blindness and sexually transmitted disease (STD) in humans.

226 provide the first quantitative evidence of a sexually transmitted disease (STD) in social insects, in

227 Trichomoniasis is a significant sexually transmitted disease (STD) in the spectrum of pu

228 s level (p = 0.02), caries score (p = 0.02), sexually transmitted disease (STD) infection experience

229 ll patients (55.5%) reported treatment for a sexually transmitted disease (STD) or incarceration in a

230 crobicides to protect against infection with sexually transmitted disease (STD) pathogens.

231 Condom use remains important for sexually transmitted disease (STD) prevention.

232 s reported to the New York City HIV/AIDS and Sexually Transmitted Disease (STD) surveillance registri

233 reactive treponemal test were extracted from sexually transmitted disease (STD) surveillance systems

234 d wives, sexual activities outside marriage, sexually transmitted disease (STD) symptoms, contracepti

235 ed as a possible cause of several idiopathic sexually transmitted disease (STD) syndromes.

236 Two randomised controlled trials of sexually transmitted disease (STD) treatment for the pre

237 United States receive cervical screening in sexually transmitted disease (STD), family planning, and

238 V seropositivity, marital status, history of sexually transmitted disease (STD), older age, and highe

239 4997829 and AD with respect to self-reported sexually transmitted disease (STD; z=-2.809, p=4.97 x 10

240 to the Jefferson County Department of Health Sexually Transmitted Diseases (STD) Clinic and receiving

241 Despite the significance for sexually transmitted diseases (STD) control in East Asia

242 n increase in high-risk sexual behaviour and sexually transmitted diseases (STD) during the time peri

243 Screening women for sexually transmitted diseases (STD) in nonclinic setting

244 Sexually transmitted diseases (STD) modeling has used co

245 5 Centers for Disease Control and Prevention sexually transmitted diseases (STD) treatment guidelines

246 ers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases (STD) Treatment Guidelines

247 uestions and data that were discussed at the Sexually Transmitted Diseases (STD) Treatment Guidelines

248 Women with sexually transmitted diseases (STDs) and bacterial vagin

249 Sexually transmitted diseases (STDs) are a major health

250 Sexually transmitted diseases (STDs) are cofactors for h

251 Sexually transmitted diseases (STDs) enhance human immun

252 For two decades, treatment guidelines for sexually transmitted diseases (STDs) have recommended em

253 viral load, and for symptoms or diagnoses of sexually transmitted diseases (STDs) in the HIV-1-infect

254 genital herpes is 1 of the 3 most prevalent sexually transmitted diseases (STDs) in the United State

255 e tested in the past year for all 3 examined sexually transmitted diseases (STDs) increased from 20%

256 The burden of sexually transmitted diseases (STDs) is high in American

257 The population prevalence of many sexually transmitted diseases (STDs) is low.

258 US surveillance of sexually transmitted diseases (STDs) is often delayed an

259 Sexually transmitted diseases (STDs) occur throughout th

260 ococcal infections and perform screening for sexually transmitted diseases (STDs) per the Centers for

261 echniques becomes more widely used for other sexually transmitted diseases (STDs) such as gonorrhea a

262 Transmission of sexually transmitted diseases (STDs) such as human immun

263 The rate of infection with any of the three sexually transmitted diseases (STDs) tested was 14.1%.

264 oup to assist in development of the 2015 CDC sexually transmitted diseases (STDs) treatment guideline

265 o evaluate methods of detecting clients with sexually transmitted diseases (STDs) who were acutely co

266 n with average semen HIV-1 loads and without sexually transmitted diseases (STDs) would be expected t

267 f patients, healthcare visits and providers, sexually transmitted diseases (STDs), and other diagnose

268 at three major infectious diseases--malaria, sexually transmitted diseases (STDs), and tuberculosis--

269 Among individuals at risk for sexually transmitted diseases (STDs), the median seropre

270 se who use these drugs raises concerns about sexually transmitted diseases (STDs).

271 urbances of vaginal flora and acquisition of sexually transmitted diseases (STDs).

272 , urinary tract infections (UTIs), and other sexually transmitted diseases (STDs).

273 ded younger age, MSM, and prior diagnoses of sexually transmitted diseases (STDs).

274 is of urinary tract infection (UTI) and some sexually-transmitted diseases (STDs), such as gonorrhea.

275 te the risk of neonatal infection (excluding sexually transmitted diseases [STDs] or congenital infec

276 Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gono

277 cular infection that leads to blindness, and sexually transmitted diseases such as pelvic inflammator

278 Associated sexually transmitted diseases (such as HIV) and suicide

279 gn of vaccines and vaccine vectors for other sexually transmitted diseases, such as AIDS.

280 or screening tests for asymptomatic women in sexually transmitted disease surveillance programs.

281 up in all sociodemographic, behavioural, and sexually transmitted disease symptom subgroups.

282 als of choice because of the similarity of a sexually transmitted disease syndrome and sequelae in sw

283 ncreasingly appreciated as a common cause of sexually transmitted disease syndromes, including urethr

284 f condoms, and significantly higher rates of sexually transmitted diseases than their peers.

285 creyi is the etiologic agent of chancroid, a sexually transmitted disease that increases the rate of

286 Chlamydia is a prevalent sexually transmitted disease that infects more than 100

287 This is true for some sexually transmitted diseases that are more easily caugh

288 ropriately assess risk for HIV infection and sexually transmitted diseases; they must inquire about b

289 sing a dynamic transmission model of HIV and sexually transmitted disease transmission that was param

290 Disease Control and Prevention published the Sexually Transmitted Diseases Treatment Guidelines 2002.

291 5 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines on hu

292 At 3 clinics for treatment of sexually transmitted disease, we recruited 521 female pa

293 th (n = 3) and without (n = 11) histories of sexually transmitted disease were evaluated.

294 Those with a history of sexually transmitted diseases were more likely and those

295 arasite that causes trichomoniasis, a common sexually transmitted disease with worldwide impact.

296 ent genital herpes is one of the most common sexually transmitted diseases, with a global prevalence

297 nalis, which causes the most common nonviral sexually transmitted disease worldwide, is itself common

298 matis is considered the most common agent of sexually transmitted disease worldwide.

299 a trachomatis is a major cause of ocular and sexually transmitted diseases worldwide.

300 ubstance abuse, motor vehicle accidents, and sexually transmitted diseases, yet little is known about